Search Results - "GUNNARSSON, I."

Arthritis in systemic lupus erythematosus is characterized by local IL‐17A and IL‐6 expression in synovial fluid by Sippl, N., Faustini, F., Rönnelid, J., Turcinov, S., Chemin, K., Gunnarsson, I., Malmström, V.

“…Summary Arthritis is a common clinical feature of systemic lupus erythematosus (SLE) and is usually non‐erosive, as opposed to rheumatoid arthritis (RA). While…”
Get full text

Altered β2‐glycoprotein I expression on microparticles in the presence of antiphospholipid antibodies by Mobarrez, F., Gunnarsson, I., Svenungsson, E.

“…Essentials β2 glycoprotein‐I (β2GPI) is a scavenger molecule that binds to microparticles (MPs). β2GPI expression on MPs was measured in systemic lupus…”
Get full text

Role of early repeated renal biopsies in lupus nephritis by Zickert, A, Sundelin, B, Svenungsson, E, Gunnarsson, I

“…Objectives A renal biopsy is generally recommended for diagnosis and is necessary for classification of lupus nephritis (LN), but second biopsies after…”
Get full text

Rituximab treatment in lupus nephritis – where do we stand? by Gunnarsson, I, Jonsdottir, T

“…Renal involvement in systemic lupus erythematosus (SLE) is a severe disease manifestation in which novel therapeutic strategies are needed, especially in…”
Get full text

Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's Syndrome by Lundtoft, Christian, Sjöwall, Christopher, Rantapää‐Dahlqvist, Solbritt, Bengtsson, Anders A., Jönsen, Andreas, Pucholt, Pascal, Wu, Yee Ling, Lundström, Emeli, Eloranta, Maija‐Leena, Gunnarsson, Iva, Baecklund, Eva, Jonsson, Roland, Hammenfors, Daniel, Forsblad‐d'Elia, Helena, Eriksson, Per, Mandl, Thomas, Bucher, Sara, Norheim, Katrine B., Auglaend Johnsen, Svein Joar, Omdal, Roald, Kvarnström, Marika, Wahren‐Herlenius, Marie, Truedsson, Lennart, Nilsson, Bo, Kozyrev, Sergey V., Bianchi, Matteo, Lindblad‐Toh, Kerstin, Yu, Chack‐Yung, Nordmark, Gunnel, Sandling, Johanna K., Svenungsson, Elisabet, Leonard, Dag, Rönnblom, Lars

“…Objective Complete genetic deficiency of the complement component C2 is a strong risk factor for monogenic systemic lupus erythematosus (SLE), but whether…”
Get full text

Pentraxin-3 - a potential biomarker in ANCA-associated vasculitis by Jonasdottir, AD, Antovic, A, Qureshi, AR, Nordin, A, Malmström, V, Gunnarsson, I, Bruchfeld, A

“…The aim of this study was to investigate pentraxin-3 (PTX3) as a potential biomarker of inflammatory activity in patients with anti-neutrophil cytoplasmic…”
Get full text

Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) by Manojlovic, M., Juto, A., Jonasdottir, A., Colic, J., Vojinovic, J., Nordin, A., Bruchfeld, A., Gunnarsson, I., Mobarrez, F., Antovic, A.

“…To investigate presence of circulating myeloperoxidase-positive microparticles (MPO + MPs) in relation to disease activity in patients with anti-neutrophil…”
Get full text

Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation by Johnston, A., Arnadottir, S., Gudjonsson, J.E., Aphale, A., Sigmarsdottir, A.A., Gunnarsson, S.I., Steinsson, J.T., Elder, J.T., Valdimarsson, H.

“…Summary Background  Obesity is a significant risk factor for psoriasis and body mass index (BMI) correlates with disease severity. Objectives  To investigate…”
Get full text

Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study by Walhelm, Tomas, Gunnarsson, Iva, Heijke, Rebecca, Leonard, Dag, Trysberg, Estelle, Eriksson, Per, Sjöwall, Christopher

“…As treatment options in advanced systematic lupus erythematosus (SLE) are limited, there is an urgent need for new and effective therapeutic alternatives for…”
Get full text

Scandinavian clinical practice guideline on fluid and drug therapy in adults with acute respiratory distress syndrome by Claesson, J., Freundlich, M., Gunnarsson, I., Laake, J. H., Møller, M. H., Vandvik, P. O., Varpula, T., Aasmundstad, T. A.

“…Background The objective of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine (SSAI) task force on fluid and drug therapy in adults with…”
Get full text

Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis by Antovic, A, Bruchfeld, A, Ekland, J, Lövström, B, Hugelius, A, Börjesson, O, Knight, A, Gunnarsson, I

“…Patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) require immunosuppressive therapy for disease control and relapse…”
Get full text

Scandinavian clinical practice guideline on mechanical ventilation in adults with the acute respiratory distress syndrome by CLAESSON, J., FREUNDLICH, M., GUNNARSSON, I., LAAKE, J. H., VANDVIK, P. O., VARPULA, T., AASMUNDSTAD, T. A.

“…Background The objective of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine (SSAI) task force on mechanical ventilation in adults with…”
Get full text

Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA by Dahlqvist, Johanna, Ekman, Diana, Sennblad, Bengt, Kozyrev, Sergey V, Nordin, Jessika, Karlsson, Åsa, Meadows, Jennifer R S, Hellbacher, Erik, Rantapää-Dahlqvist, Solbritt, Berglin, Ewa, Stegmayr, Bernd, Baslund, Bo, Palm, Øyvind, Haukeland, Hilde, Gunnarsson, Iva, Bruchfeld, Annette, Segelmark, Mårten, Ohlsson, Sophie, Mohammad, Aladdin J, Svärd, Anna, Pullerits, Rille, Herlitz, Hans, Söderbergh, Annika, Rosengren Pielberg, Gerli, Hultin Rosenberg, Lina, Bianchi, Matteo, Murén, Eva, Omdal, Roald, Jonsson, Roland, Eloranta, Maija-Leena, Rönnblom, Lars, Söderkvist, Peter, Knight, Ann, Eriksson, Per, Lindblad-Toh, Kerstin

“…Abstract Objective To identify and characterize genetic loci associated with the risk of developing ANCA-associated vasculitides (AAV). Methods Genetic…”
Get full text

Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitis by Ekman, Diana, Sennblad, Bengt, Knight, Ann, Karlsson, Åsa, Rantapää-Dahlqvist, Solbritt, Berglin, Ewa, Stegmayr, Bernd, Baslund, Bo, Palm, Øyvind, Haukeland, Hilde, Gunnarsson, Iva, Bruchfeld, Annette, Segelmark, Mårten, Ohlsson, Sophie, Mohammad, Aladdin J, Svärd, Anna, Pullerits, Rille, Herlitz, Hans, Söderbergh, Annika, Omdal, Roald, Jonsson, Roland, Rönnblom, Lars, Eriksson, Per, Lindblad-Toh, Kerstin, Dahlqvist, Johanna

“…Abstract Objective To identify and genetically characterize subgroups of patients with ANCA-associated vasculitides (AAV) based on sex and ANCA subtype…”
Get full text

Dysregulations in circulating sphingolipids associate with disease activity indices in female patients with systemic lupus erythematosus: a cross-sectional study by Checa, A, Idborg, H, Zandian, A, Sar, D Garcia, Surowiec, I, Trygg, J, Svenungsson, E, Jakobsson, P-J, Nilsson, P, Gunnarsson, I, Wheelock, C E

“…Objective The objective of this study was to investigate the association of clinical and renal disease activity with circulating sphingolipids in patients with…”
Get full text

Immunoglobulin A anti‐phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual by Frodlund, M., Vikerfors, A., Grosso, G., Skogh, T., Wetterö, J., Elvin, K., Gunnarsson, I., Kastbom, A., Dahlström, Ö., Rönnelid, J., Svenungsson, E., Sjöwall, C.

“…Summary Immunoglobulin (Ig) G‐ and IgM‐class anti‐cardiolipin antibodies (aCL) and lupus anti‐coagulant (LA) are included in the 1997 update of the American…”
Get full text

Rituximab-mediated late-onset neutropenia in systemic lupus erythematosus – distinct roles of BAFF and APRIL by Parodis, I, Söder, F, Faustini, F, Kasza, Z, Samuelsson, I, Zickert, A, Svenungsson, E, van Vollenhoven, R F, Malmström, V, Wermeling, F, Gunnarsson, I

“…Objective Rituximab-mediated late-onset neutropenia (LON) has been described in various diseases. We investigated its occurrence, consequences and contributing…”
Get full text

False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases by Kharlamova, Nastya, Dunn, Nicky, Bedri, Sahl K, Jerling, Svante, Almgren, Malin, Faustini, Francesca, Gunnarsson, Iva, Rönnelid, Johan, Pullerits, Rille, Gjertsson, Inger, Lundberg, Karin, Månberg, Anna, Pin, Elisa, Nilsson, Peter, Hober, Sophia, Fink, Katharina, Fogdell-Hahn, Anna

“…Patients with chronic inflammatory diseases are often treated with immunosuppressants and therefore are of particular concern during the SARS-CoV-2 pandemic…”
Get full text

Belimumab for systemic lupus erythematosus: a practice-based view by Parodis, I, Axelsson, M, Gunnarsson, I

“…Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder with multiple organ involvement. B-lymphocyte activity plays a pivotal role in the…”
Get full text

Heart and kidney transplant: should they be combined or subsequent? by Melvinsdottir, Inga, Foley, David P., Hess, Timothy, Gunnarsson, Sverrir I., Kohmoto, Takushi, Hermsen, Joshua, Johnson, Maryl R., Murray, David, Dhingra, Ravi

“…Aims End‐stage heart failure patients often present with severe kidney failure and have limited treatment options. We compared the clinical characteristics and…”
Get full text